BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Mazor Robotics Receives First Renaissance System Order From Transmedic Pte Ltd, Southeast Asian Distributor


10/23/2012 9:25:15 AM

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE:MZOR), a developer of innovative surgical robots and complementary products, today announced it received its first Renaissance™ system order from Transmedic Pte Ltd, a leading specialty partner of healthcare institutions and professionals in Southeast Asia. The system purchased will be placed in Viet Duc Hospital in Hanoi, Vietnam. A public hospital with 1000 beds, Viet Duc Hospital is the largest surgical health care center in Vietnam. The hospital specializes in complicated surgeries and diagnoses and the treatment of difficult diseases. Founded in 1980, Transmedic distributes and promotes the latest medical technologies to the countries of Southeast Asia – Singapore, Malaysia, Indonesia, Thailand, Brunei, Vietnam and the Philippines. “Transmedic is pleased to partner with Mazor to deliver the latest spinal robotics technology to the Southeast Asian market,” commented Teo Kee Meng, Managing Director of Transmedic. “We aspire to play a key role in bringing the world’s leading medical products and their benefits to this region, and we believe the introduction of Renaissance will greatly improve spinal operations for the region’s patients.”

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->